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Abstract
The benefits and risks of nutritional therapies in the prevention and management of infectious
diseases in the developed world are reviewed. There is strong evidence that early enteral feeding
of patients prevents infections in a variety of traumatic and surgical illnesses. There is, however,
little support for similar early feeding in medical illnesses. Parenteral nutrition increases the risk of
infection when compared to enteral feeding or delayed nutrition. The use of gastric feedings
appears to be as safe and effective as small bowel feedings. Dietary supplementation with glutamine
appears to lower the risk of post-surgical infections and the ingestion of cranberry products has
value in preventing urinary tract infections in women.
Background
One of the earliest responses to infection is cytokine-
mediated anorexia. Interleukins 1, 6, 8 as well as tumor
necrosis factor and interferon alpha are released by host
defense mechanisms. These cytokines reduce nutrient
intake through effects on the central nervous system [1].
They also cause the sequestration of critical nutrients such
as iron, copper and zinc in order to allow the host to gain
an advantage over invading organisms [2]. Is it a benefit
to bypass the action of the body's host defense mecha-
nisms by feeding patients who do not or cannot ingest
their normal diet?
The developed world is rife with calories and nutrients. Is
there a benefit from nutritional supplements in prevent-
ing infections in societies where the availability of nutri-
ents is not limited?
Physicians are often asked about the role of various nutri-
tional interventions in preventing or treating infectious
diseases. What is known about the value of these interven-
tions?
This review will not deal with nutritional interventions in
populations which often suffer dietary deficiencies. As
such, it will include only studies done in economically
developed nations. Finally, it will review the use of cran-
berry products and yogurt as these are available in any
grocery store, but not the myriad of botanical products
sold for their medicinal value.
In order to clarify what is known about the risks and ben-
efits of nutrition in the developed world, I have reviewed
the English language publications available on MEDLINE
(1966–2006) and in the Cochrane Library which deal
with nutrition and infection. All articles including the
words "nutrition", "vitamin(s)", "cranberry" or "yogurt"
and the words "infection" or "infectious" in their abstracts
were reviewed. Articles were included if they were struc-
tured to compare differing nutritional interventions.
Prevention of infection in the general population and the 
institutionalized
Is nutritional therapy of value in preventing infectious dis-
eases in the developed world? There is a large body of evi-
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dence that supports the thesis that insufficient intake of
dietary protein adversely affects the immune system and
predisposes the malnourished to infectious diseases [3-5].
This inadequate protein intake is usually coupled with
reduced intake of calories and is referred to as protein-cal-
orie malnutrition (PCM).
Protein
Since there are no prospective studies in which protein
intake is manipulated in order to assess infection risk in
non-hospitalized people, indirect studies must be evalu-
ated. The use of serum albumin as an indicator of protein
intake is fraught with problems as chronic illnesses in
themselves may prevent adequate protein intake and may
inhibit the synthesis of albumin [6].
Preoperative albumin levels have been shown to correlate
with the postoperative risk for pneumonia, urinary tract
infections and wound infections in a large Veterans
Administration study [7]. This study did not deal directly
with nutrition, however. A more relevant study looked at
1,023 acute trauma patients admitted to a Baltimore hos-
pital. Since these patients were acutely ill due to a non-
medical condition, their albumin levels were more likely
to reflect previous nutritional status rather than previous
medical illness. There was a 48% incidence of infection in
those admitted with a serum albumin of less than 2.6
gms/dL and a 28% incidence in those with an albumin of
2.6 gms/dL or above (p < 0.001). The infections were pre-
dominately respiratory and urinary in nature [8].
This evidence indirectly supports adequate protein intake
as a factor in preventing infections after trauma.
Multivitamins and zinc
Studies have shown that most elderly patients fail to
ingest the recommended daily allowance (RDA) of zinc.
Supplementation with zinc could improve their immune
responses to infection and thus prevent illness. Zinc sup-
plementation for people aged 60–89 (defined as elderly)
alone increased their in vitro lymphocytes' response to
mitogens [9]. Their response to skin test antigens how-
ever, was not increased. When 15 mg of zinc was added to
a multivitamin preparation and compared to a lactose
placebo given to people aged 59–85 living in northern
New Jersey, there was a significant increase in skin test
responses to a panel of seven intradermal antigens [10].
The incidence of infectious diseases was not studied.
There is a considerable literature concerning the use of
zinc as a therapy for the common cold. Marshall has
reviewed 8 such studies and concludes that there is no
convincing evidence as to zinc's efficacy in reducing the
severity or duration of cold symptoms [11].
There is evidence that zinc supplementation significantly
reduces the incidence of infections in people with sickle
cell disease. Twenty-one of 32 sickle cell disease patients
in the Detroit area were found to have zinc deficiency as
determined by lymphocyte or granulocyte zinc levels.
Zinc supplementation in those deficient reduced their
documented infection rate by as much as 80% [12]. Their
hospitalization rate, however, was unaffected.
Multivitamin and mineral supplementation has not been
shown to affect illness or absenteeism rates in 158 adults
(age >45 years old) living in North Carolina unless they
had type II diabetes [13]. Diabetics taking a placebo
reported a 93% incidence of infection (as opposed to an
incidence in non-diabetics of 60%). Strangely, diabetics
taking supplementation showed only a 17% incidence of
infection-much lower than non-diabetics taking placebo.
The infections did not result in hospitalizations. Elderly
people (>60 years old) living in central France had no
decrease in infection incidence when receiving a multivi-
tamin supplementation as compared to a placebo [14]. A
prospective study relating the intake of carotenoids, vita-
mins C and E and B-vitamins with the incidence of com-
munity acquired pneumonia in over 50,000 U. S. male
health professionals aged 40–75 years old failed to show
any correlation between pneumonia risk and vitamin
intake [15]. This study looked at both food and supple-
ment sources of vitamins. "Natural" vitamins therefore
seemed to be no better than "pharmaceutical" vitamins in
preventing pneumonia in this well-educated population
of American men. Elderly nursing home residents in the
Boston area were given multivitamins with either 4 IU of
vitamin E (50% of the RDA) or 200 IU of vitamin E. High
intake of vitamin E had no effect on the incidence or dura-
tion of lower respiratory tract infection [16]. There
appeared to be a small, but significant effect on the inci-
dence of upper respiratory tract infections (including oti-
tis media), but not on their duration (risk ratio = 0.84 for
incidence, but 1.53 for duration).
There are two studies which support the use of vitamin or
micronutrient supplementation to prevent community-
acquired infections. Chandra [17] showed that trace ele-
ments and multivitamins reduce the number of days with
any sort of infection. The study enrolled 96 elderly New-
foundland residents and is apparently the only other
study to show such an effect in those not institutionalized.
A French study gave a placebo, zinc and selenium supple-
ments, or multivitamins with zinc and selenium to insti-
tutionalized people over the age of 65 [18]. The sample
size was a total of 81 and over a two year follow-up
period, they found that the number of pneumonias and
UTIs decreased by about 50% in those who received theNutrition Journal 2006, 5:21 http://www.nutritionj.com/content/5/1/21
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zinc and selenium with or without multivitamins. The
multivitamins had no statistically significant effect alone.
If there is little or no effect of micronutrient and multivi-
tamin supplementation on infection rates on apparently
uninfected members of the community, how about those
chronically infected with viruses? A small study from the
era prior to the availability of effective anti-HIV therapy
studied nutrient and vitamin intake in 56 HIV infected
New Yorkers. Vitamin intake varied from 2% to 50,000%
of the RDA. No correlation could be found between nutri-
ent intake and CD4 lymphocyte count or absolute lym-
phocyte count [19].
A more intriguing study of HIV-infected people in Balti-
more correlated their micronutrient intake as estimated
by data from a questionnaire and the subsequent progres-
sion of HIV disease [20]. This study did not take any
changing dietary habits into account. The study correlated
any intake of zinc supplements with decreased survival.
High intake of vitamins B1, B2 and B6 were correlated with
increased survival. Studies of this nature always raise the
question of whether the increased intake reflected a
healthier life style or produced a healthier life. A review of
fifteen studies utilizing vitamin and micronutrient sup-
plementation in HIV-infected people concluded that such
supplementation effected no reduction in mortality or
morbidity in HIV-infected adults. HIV-infected children
in under-developed countries could benefit from vitamin
A supplementation, however [21].
Hepatitis C has a prevalence between 1% and 2% in the
U. S. population. Could nutritional therapy affect the pro-
gression to cirrhosis or hepatoma? The only vitamin sup-
plementation studies done with hepatitis C involve the
use of vitamin E as an anti-oxidant to limit hepatic fibrosis
[22]. Two studies which show decreased transaminase lev-
els when patients with hepatitis C are given supplemental
vitamin E [23,24] although there is no data on vitamin E's
effect on the viral load.
Vitamin C
The RDA for vitamin C is between 45 and 60 mg per day.
The writings of Linus Pauling have popularized the use of
vitamin C as a prophylactic and therapeutic agent for the
common cold [25]. The nutritional value of a vitamin
ingested at more than 10 times its RDA begs the question
of whether the vitamin is nutritional or pharmacologic. A
comprehensive meta-analysis has been published [26]
which finds that huge doses of vitamin C have a minimal
effect on reducing cold symptoms. No effect on cold pre-
vention could be found unless groups undergoing hypo-
thermic stress were studied.
There is a published study which supplemented British
patients over the age of 65 with a placebo or 200 mg of
vitamin C if they were admitted to hospital with bronchi-
tis or pneumonia [27]. The patients were followed for 4
weeks. If patients who died were excluded from the anal-
ysis, the study showed that vitamin C administration less-
ened the symptom score of surviving patients. Only one of
the six deaths in the study occurred in a vitamin C recipi-
ent, but the sample size was too small (n = 57) to show
significance.
Cranberry juice
Many people believe that drinking cranberry juice will
treat or prevent urinary tract infections. There is evidence
that cranberry juice contains anti-adhesive molecules
which could interfere with bacterial virulence mecha-
nisms [28]. Cranberry juice (300 ml/day) or a colored
drink containing no cranberry products were provided to
female residents of a long-term care facility in Boston
[29]. Monthly urine samples were analyzed. At one
month, the percentage of urine samples with more than
100,000 CFU/ml of urine was identical whether or not
cranberry juice was ingested. After one month, there was a
consistent decrease in high-grade bacteriuria in the cran-
berry juice drinkers. The calculated relative risk for bacte-
riuria with pyuria for cranberry drinkers was 0.42 (p =
0.0004). Antibiotic use for UTI was almost halved in those
drinking cranberry juice. In this study, the distinction
between UTI prevention and treatment is unclear, but its
ability to obviate the use of antibiotics is significant.
A Canadian study randomized 150 sexually active women
who had ≥ 2 UTIs in the previous year into three groups:
1) 250 ml of diluted pineapple juice (colored red) thrice
daily and a placebo tablet twice daily; 2) A concentrated
cranberry extract tablet twice daily and placebo juice; 3)
250 ml of cranberry juice thrice daily and a placebo tablet
[30]. The study continued for a year. Symptomatic infec-
tions were treated with antibiotics for 3 days and the
prophylaxis restarted. The placebo group showed 32% of
entrants with at least one UTI during the year of study. The
tablet group had 18% with at least one infection and the
cranberry juice group had 20%. The difference between
the tablet or juice groups and placebo was significant (p <
0.05). The mean number of UTIs per year was approxi-
mately halved by the use of a cranberry product.
The daily ingestion of cranberry juice concentrate or a pla-
cebo did not affect bacteriuria rates in children requiring
intermittent catheterization [31].
There is sufficient reason based on these two positive stud-
ies and others reviewed by Raz et al [29] to recommend a
cranberry product to women with recurrent UTIs.Nutrition Journal 2006, 5:21 http://www.nutritionj.com/content/5/1/21
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Yogurt
Yogurt is cow's milk usually fermented using two synergis-
tic bacterial species Lactobacillus delbrueckii subspecies bul-
garicus and Streptococcus thermophilus. The amount of fat
and even the bacteria used to ferment the milk may vary
from study to study. The presence or absence of living bac-
teria must be kept in mind when evaluating studies which
employ yogurt. There are few randomized studies in
which yogurt (as opposed to lactobacilli or yeast in pure
form) is administered in the developed world. Beniwal et
al gave 109 American patients 227 grams of vanilla fla-
vored yogurt twice daily for 8 days if they were receiving
intravenous or oral antibiotics [32]. The yogurt contained
L. acidophilus as well as L. bulgaricus and S. thermophilus.
The control group of 97 patients received no yogurt. The
mean number of days of yogurt intake was 6.6 days.
Diarrhea as defined by 3 or more loose bowel movements
per day was reported in 13% of yogurt ingesters and 23%
of those not eating yogurt. The duration of diarrhea was
not significantly decreased. Israeli soldiers eating yogurt
with living L. casei did not have fewer diarrheal episodes
than those soldiers eating yogurt containing no living bac-
teria [33]. The study had approximately 250 soldiers in
each arm and the mean incidence of diarrhea was 14%. If
there were an undetected effect, it would have had to be a
small one.
While not a nutritional therapy per se lactobacilli are used
by those who do not tolerate yogurt or find it unfeasible.
Lactobacillus casei strain GG was administered in capsules
(not yogurt) to American children receiving concurrent
antibiotics. The living bacteria reduced the percentage of
children with diarrhea (defined as more than one liquid
stool/day) from 26 to 8% when compared to an inulin
placebo [34]. A Finnish study using Lactobacillus strain GG
found that recovery from diarrhea was one day quicker on
average in those children that received living bacteria in
capsular form as opposed to children who received a pla-
cebo [35]. The same Lactobacillus casei strain reduced the
incidence of antibiotic-associated diarrhea in Finnish chil-
dren from 16% to 5% [36].
When the effect of the same GG strain was used to prevent
antibiotic associated diarrhea in American adults, the
results were disappointing. A study analyzed 268 hospital-
ized patients and found almost identical diarrhea rates
and frequencies in those receiving the live bacteria and in
those receiving a placebo [37].
The "non pathogenic" yeast Saccharomyces boulardii has
been shown to reduce antibiotic-related diarrhea in hospi-
talized Americans when administered in capsule form
[38]. Enthusiasm for this therapy has waned due to
reports such as that of 7 French patients who developed
fungemia after ingesting this yeast in the setting of an
intensive care unit [39].
The ability of yogurt or lactobacilli to prevent diarrhea is
still in question. Should yogurt contain living bacteria?
Do the species of bacteria matter? Can yogurt be made
with skim milk? Does the flavoring matter? How much
yogurt should be ingested? These questions probably will
never be answered. At present, yogurt cannot be recom-
mended as a proven method of diarrhea prevention.
Table 1 summarizes the effects of various nutritional
interventions on infections in the general population and
in institutionalized people.
Table 1: Summary of randomized, controlled trials of the impact of nutritional interventions on infections in the non-hospitalized 
population
Intervention Effect Reference
Zinc supplementation No effect on common colds 11
Zinc supplementation reduced infection incidence in sickle cell patients 12
Zinc and selenium supplementation Reduced infection incidence 18
Vitamin and mineral supplementation Reduced infection incidence in type II diabetics only 13
Vitamin and mineral supplementation Reduced infection incidence 17
Multivitamin supplements No effect on infection incidence 14
Multivitamin supplements No effect on pneumonia incidence 15
Vitamin E supplements Reduced URI rate, no effect on lower respiratory tract rate 16
Vitamin C therapy or supplements No effect on common cold unless used in hypothermic conditions 26
Cranberry juice Reduced incidence of bacteriuria 29, 30
Yogurt Reduced diarrhea incidence in adults taking antibiotics 32
Yogurt No effect on diarrhea incidence 33
Lactobacilli Reduced incidence of diarrhea in children 34–36
Lactobacilli No effect on diarrhea incidence in adults 37Nutrition Journal 2006, 5:21 http://www.nutritionj.com/content/5/1/21
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Pre-operative nutrition
If the value of nutritional supplementation in the general
citizenry of developed countries is unproven, how about
for those about to undergo surgery?
A pre-operative cohort of 192 malnourished American
veterans were randomized to receive total parenteral
nutrition (TPN) and 203 control malnourished patients
received conventional nutrition [40]. Malnutrition was
defined by serum albumin or prealbumin levels, by a
body weight ≤ 95% of ideal or a score ≤ 100 on the Nutri-
tion Risk Index. The Nutrition Risk Index uses body
weight and serum albumin to calculate a malnutrition
score. The TPN patients received therapy for at least seven
preoperative days whereas the conventional patients went
to surgery within 3 days. The TPN patients received TPN
postoperatively for at least 72 hours. Conventional
patients received no parenteral or enteral post operative
feedings for 72 hours. After that time, they could receive
whatever form of nutrition thought best. Overall infec-
tious risk in a 30-day post operative period was 14.1% in
the TPN group and 6.4% in the conventional group (p =
0.01). The bacteremia/fungemia rates for TPN patients
were 4.2% vs 2.5% and the rate of pneumonias was
almost double that of the conventional group when
patients were stratified by degree of malnutrition. The
most severely malnourished TPN patients had a 12.9%
infectious complication rate as opposed to a 10.5% rate in
the severely malnourished conventional patients. The pre-
operative TPN course did not therefore ameliorate the
infectious risk-if anything it exacerbated it.
Early vs. late nutrition
Patients who have undergone trauma or surgery need to
be fed eventually. Would early feeding prevent or increase
the rate of infections? There are several studies that exam-
ine various subsets of these patients.
Nasojejunal tubes were placed in 17 Arizona head trauma
patients and feeding started within 36 hours of admission
[41]. Feeding of the 15 control patients was by the
nasogastric route and never before 72 hours. The patients
were studied only for 7 days after admission. In this short
time period, there were 14 infections in the late feeding
group and only 3 in the early feeding group. The predom-
inant infection was "bronchitis" – a diagnosis whose cri-
teria were not defined. Since this study was not blinded,
observer bias would be hard to eliminate. A similar study
was done in Tennessee using 30 patients fed nasogastri-
cally before 72 hours or after gastric ileus was resolved
[42]. There was no difference in the incidence of pneumo-
nia or infections in general. A small study enrolling cervi-
cal trauma patients also failed to show an advantage with
early enteral feeding [43].
Sixty-three abdominal trauma patients requiring celiot-
omy were entered into a study in which half the patients
received intravenous glucose for the first five post-opera-
tive days and the other half had an immediate percutane-
ous jejunal feeding tube placed through which was
administered an elemental diet [44]. Patients fed immedi-
ately had a "sepsis" rate of 9% while those not fed for five
days had a rate of 29% in the first seven days (p < 0.05).
Unfortunately, "sepsis" was not further defined. A meta-
analysis of early feeding in patients undergoing gastroin-
testinal surgery included 11 studies and 837 patients [45].
The patients were fed either orally or by jejunal feeding.
Early was defined as within 24 hours of surgery. The rela-
tive risk of all infections was 0.72 in favor of early feeding.
The risk of pneumonia was between 0.7 and 0.8 and the
risk of intra-abdominal abscess was between 0.8 and 0.9.
The rationale behind early enteral feeding in gastrointesti-
nal surgery is based on the putative increase in intestinal
epithelial health and decreased translocation of intestinal
flora into the systemic circulation. Numerous studies
seem to confirm early enteral feedings' value in abdomi-
nal surgery, whether or not the rationale is valid. The ben-
efit of early feeding has not been found in acutely burned
children who were fed within 24 hours of the burn as
opposed to after 48 hours [46], but the mean difference of
33 hours in delaying nutrition cannot be said to be large.
A review of 15 studies incorporating abdominal surgery,
trauma, head injury and burns came to the conclusion
that early (within 36 hours) enteral feeding yielded a sig-
nificantly decreased rate of infection (19% vs 41% p =
0.049). There was considerable heterogeneity amongst
the studies, with abdominal surgery studies having the
most convincing risk reduction [47].
The benefit of early feeding in trauma and surgery patients
does not appear to generalize to early enteral feeding in
those with severe medical illnesses.
The FOOD study looked at the benefit of early tube feed-
ing in dysphagic stroke patients from around the world
[48]. Four hundred and thirty patients were randomized
to avoid any enteral tube feedings for 7 days as opposed
to 429 allocated to nasogastric or percutaneous endo-
scopic gastrostomy (PEG) feeding within 3 days of enroll-
ment. Early feeding had no effect on the rates of
pneumonia or urinary tract infections. Nor was there an
effect on survival by delaying feeding for seven days.
All patients ventilated in a St. Louis ICU received an oro-
gastric tube. Early-fed patients (n = 75) received their
nutritional requirements from day 1, while the late fed (n
= 75) patients received 20% of their requirements for 4
days and then their feedings were increased to their calcu-
lated optimal level [49]. The early feeding group had noNutrition Journal 2006, 5:21 http://www.nutritionj.com/content/5/1/21
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fewer bacteremias or UTIs. The early feeding group had
65% more antibiotic days than the late feeding group (p <
0.001) and their length of stay in the ICU was almost
twice as long. Ventilator-associated pneumonias occurred
in 37% of the early feeding group as opposed to 23% of
the late feeding group (p = 0.02). The size of this study
and its' quality argues against an infectious benefit by
early feeding of medical patients requiring ventilation.
The route of nutrition delivery
Is there significant benefit or risk associated with the route
chosen for delivery of nutrition? Would total parenteral
nutrition (TPN) increase the bacteremia rate, but decrease
the incidence of aspiration pneumonia, for instance?
Could jejunal feeding reduce the likelihood of esophageal
reflux and thus lower the pneumonia rate when compared
to gastric feeding?
Gastric vs non-gastric enteral feeding
Gastrostomy feeding of 10 neurologically dysphagic
patients was compared to 20 fed by nasogastric tube in
Scotland [50]. The nasogastric tube was a "fine bore" 20
French tube. After 28 days, the gastrostomy patient group
suffered two aspiration pneumonias and one wound
infection versus no pneumonias for the nasogastric group.
Another small study compared ventilated Canadian
trauma patients receiving gastric versus duodenal feedings
via nasal or oral tubes. Forty three gastrically fed patients
had 18 clinically diagnosed pneumonias versus 10 pneu-
monias in the 37 patients receiving duodenal feedings. No
difference was statistically discernible with the sample size
used. Nasogastric and nasoduodenal feeding of ventilated
patients was compared in 44 California medical ICU
patients [51]. The pneumonia, bacteremia and mortality
rates were indistinguishable.
Jejunal feedings were compared to gastric feedings in 38
Boston medical and surgical ICU patients. The jejunal
tubes were placed perorally. About half of each group was
ventilated. Two gastrically fed patients developed pneu-
monia versus none of the jejunally fed [52]. Such a small
study is not convincing.
Two meta-analyses have been published which analyzed
the differences between gastric and non-gastric enteral
feeding. One [53] found a relative risk of 0.76 of develop-
ing a pneumonia for small bowel (duodenal or jejunal)
feedings. The other [54] found no proven benefit in pre-
venting pneumonia by employing small bowel feedings.
The consensus statement of a North American summit on
aspiration in critically ill patients likewise concluded that
good evidence does not exist for small bowel feedings
unless proven aspiration occurs and then jejunal feedings
were recommended [55]. This consensus group did rec-
ommend continuous enteral feeding rather than bolus
feeding apparently based on the study carried out on 60
Nebraskan patients receiving nasogastric feedings [56].
This study only followed elderly patients for seven days.
All patients were assessed clinically for aspiration and
continuously fed patients had one-half the aspiration rate
of intermittently fed patients. This difference was not sta-
tistically significant.
TPN vs enteral nutrition
There are many small trials in various sub-groups of
patients (i.e.: lymphoma, radiotherapy) comparing
enteral and total parenteral nutrition. This review will dis-
cuss only meta-analyses of various subgroups for the sake
of brevity as the findings are remarkably homogenous. A
large meta-analysis of 7 studies comparing TPN with
standard care and 20 studies comparing tube feeding to
TPN was done by Braunschweig et al [57]. A total of 1,828
patients were included in these randomized prospective
studies. Standard care patients had a relative risk of infec-
tion of 0.77 when compared to TPN and enterally fed
patients had a relative infection risk of 0.66. If catheter
infections were excluded from the meta-analysis, the
increased risk of infection associated with TPN persisted.
A much smaller meta-analysis using mostly unpublished
studies was done on 230 surgical and trauma patients
[58]. The overall risk of infection complications was 2.5
times higher (p = 0.0001) in those randomized to TPN as
opposed to enteral feedings early in the course of hospi-
talization. Rather than increasing the risk of aspiration
and pneumonia, enteral feedings reduced that overall risk
of pneumonia to 40% of that seen in TPN patients.
Since pancreatitis causes severe inflammation which may
lead to transluminal spread of bacteria, it would be rea-
sonable to suppose that TPN would decrease the infec-
tious risks in patients with pancreatitis by decreasing
pancreatic activity. The combined risk for infection for
pancreatitis patients in two trials (n = 70) of enteral feed-
ing was 0.61 when compared to the TPN route [59].
Chemotherapy patients may have long periods of ano-
rexia and poor nutrition. Would TPN mitigate this malnu-
trition and allow a more vigorous defense against
infection? Many small studies examining this question
were published in the 1980's and 1990's. None showed
an infection benefit with TPN. A meta-analysis of 15 stud-
ies comparing TPN with routine care was published in
1990 [60]. Three month survival and chemotherapy
response were not improved by the use of TPN. The risk of
infection was 3.2 times higher in those receiving TPN (p <
0.005) even if catheter-related infections were excluded
from the analysis. If catheter infections were included, the
risk of infection was 4 times greater in those receiving
TPN. A recent Brazilian study [61] found that a centralNutrition Journal 2006, 5:21 http://www.nutritionj.com/content/5/1/21
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venous catheter through which TPN was given had a 3.3
times greater risk of becoming infected than a similar
catheter not used for TPN.
Is the flood of intravenous nutrients responsible for the
increased rate of infections seen with TPN or is it the lack
of enteral feeding and the presence of a central venous
catheter? Some insight into the answer is gained by the
result of studies comparing TPN with intravenous feed-
ings of other types.
A study of 248 Swedish post-operative patients were ran-
domized to TPN or glucose and electrolyte solutions until
they could eat and drink "freely" without the use of any
intravenous support [62]. They found that those sup-
ported with glucose and electrolytes had a 5% mortality as
opposed to 2% with TPN, but this difference was not sig-
nificant. Both groups had similar rates of wound infec-
tions and pneumonia. Similar results were seen in 117
post-pancreatic resection patients in New York [63].
Reducing the amount of glucose and protein in the TPN
admixture did not affect the infection rate in 40 patients
with a variety of underlying conditions. Six of 21 hypo-
caloric TPN patients developed infections as did 10 of 19
standard TPN patients. This difference is not statistically
significant due to the small sample size [64]. Thus, there
is no data to support the idea that increased delivery of
nutrients intravenously alone increases the rate of non-
catheter infection, but the size of the samples and the
duration of the TPN may be an important variable in these
studies. Enteral feedings seem to protect against infection.
There are several potential explanations for this apparent
protection provided by enteral feedings. There is evidence
reviewed by Kudsk [65] that levels of IgA and numbers of
circulating lymphocytes from gut-associated lymphoid
tissue are strongly affected by enteral feeding. These lym-
phocytes migrate to non-gut tissues such as the lung and
can alter the immune response in non-gut locales. The
neuroendocrine system of the gut also affects the regula-
tion of inflammation outside of the gut. This neuroendo-
crine system is modulated by the presence of dietary
constituents [66,67]. The value of enteral feeding may be
thus dependent on cellular and neuroendocrine factors.
The value of nutritional supplements in the critically ill
There are many nutritional additives which are hypothe-
sized to improve host defenses by boosting immunity and
are called by some immuno-nutrients [68]. A meta-analy-
sis compared published studies using two different
"immunologically enhanced" enteral feedings with stand-
ard enteral feeding mixtures. These two "enhanced" mix-
tures had increased amounts of arginine, omega-3 fatty
acids and nucleotides when compared with standard feed-
ings. One of the feeding mixtures had added glutamine as
well [69]. All studies analyzed enrolled critically ill medi-
cal and surgical patients. Although there was no detecta-
ble mortality benefit to enhanced feedings, there was an
overall reduction in infectious risk to 0.60 (p < 0.005). No
statistically significant infectious benefit could be found if
only medical patients were analyzed (p = 0.30).
When studies enrolling only cancer patients are analyzed,
no significant benefit of enhanced enteral nutrition was
found in reducing nosocomial pneumonia. Effects on
other infections were not analyzed. There was no signifi-
cant effect of enhanced feeding on length of hospital stay
or mortality [70]. If the enhanced feedings were started 7
days before cancer surgery and continued after the sur-
gery, there was evidence of an infectious benefit in 206
Italian patients [71]. The pneumonia rate was more than
twice as high in those receiving non-enhanced nutrition
and the overall infection in the standard nutrition group
was 30% compared to 14% in the enhanced nutrition
group (p = 0.009).
When a routine hospital diet feeding was compared with
a diet supplemented with 22.5 grams of extra protein and
extra calories, there was no infectious risk benefit for
stroke patients. A large multinational trial involving 4,023
patients showed no difference in pneumonia or urinary
tract infection rates. The rate of developing pressure ulcers
was not altered by supplementation either [72].
An innovative form of nutritional supplement was given
to Hungarian patients with pancreatitis [73]. Twenty-
three control and 22 experimental patients received naso-
jejunal feedings for 7–10 days. The control group also
received 10 grams of oat fiber twice a day as well as 10 bil-
lion heat-killed Lactobacillus plantarum. The experimental
group received the oat fiber and living bacteria. Seven con-
trol patients and only 1 experimental patient had a posi-
tive pancreatic aspiration culture (p = 0.05). Seven control
patients required surgery to control sepsis compared to
one experimental patient. The hypothesis that the compo-
sition of the enteral flora affects the rate of sepsis is sup-
ported by this study.
There is considerable literature regarding the amino acid
glutamine's ability to preserve enterocyte integrity and
reduce bacterial translocation from the gut [74]. When
Dutch trauma patients received enteral nutrition or
glutamine-supplemented enteral nutrition (which was
iso-nitrogenous and iso-caloric), the glutamine supple-
mented group showed a definite infectious benefit [75].
There were fewer pneumonias (17% vs 43%) and bacter-
emias (9% vs 38%). A study of Spanish ICU patients with
systemic inflammatory response syndrome yielded simi-
lar results for enteral glutamine supplementation [76].Nutrition Journal 2006, 5:21 http://www.nutritionj.com/content/5/1/21
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The pneumonia incidence was about halved in the
glutamine group (p = 0.04), although the incidence of
bacteremia was unaffected by glutamine supplementa-
tion.
Glutamine need not apparently be given enterally to
detect an infectious benefit. Burn patients receiving intra-
venous glutamine were compared with those receiving an
iso-nitrogenous amino acid mixture. Only 1 of 12
glutamine patients had a Gram-negative bacteremia com-
pared to 6 of 14 control patients (p = 0.04). The Gram-
positive bacteremia and fungemia rates were unaffected
by glutamine infusion [77]. Intravenous supplementation
glutamine decreased bacteremias in bone marrow trans-
plant patients when compared with parenteral nutrition
without glutamine supplementation [78].
Table 2 summarizes the effect of various nutritional inter-
ventions on infections in hospitalized patients.
Conclusion
The literature concerning nutrition and infectious diseases
in the developed world contains mixed support for ideas
that nutritional supplements serve to prevent infectious
diseases. While there is good evidence that enterally feed-
ing those who have sustained surgical or accidental
trauma prevents infections, other circumstances may
implicate nutrition as a risk factor for infection rather than
as a benefit. The following general points can be sup-
ported:
1. There is inconsistent evidence that healthy elderly and
diabetic people can decrease their infectious risk by taking
multivitamins and micronutrient supplementation.
2. Cranberry juice or concentrate can reduce bacteruria in
women.
3. Yogurt or lactobacilli have an inconsistent effect in
treating or preventing diarrhea.
4. Nutritional supplements offer little benefit in prevent-
ing infection in those already ill. The exception may be
glutamine supplementation.
5. Enteral feeding is superior to parenteral feeding in less-
ening infectious risk.
6. Early enteral feeding in trauma and surgical patients
prevents infections.
7. There is no best site for the delivery of enteral feedings.
Gastric feedings do not appear to increase the risk of aspi-
ration pneumonia when compared to small bowel feed-
ings.
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